156 related articles for article (PubMed ID: 36281585)
1. Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal status.
Kotsafti A; Fassan M; Cavallin F; Angerilli V; Saadeh L; Cagol M; Alfieri R; Pilati P; Castoro C; Castagliuolo I; Scarpa M; Scarpa M
Cancer Med; 2023 Mar; 12(5):5526-5535. PubMed ID: 36281585
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.
Barbetta A; Schlottmann F; Nobel T; Sewell DB; Hsu M; Tan KS; Gerdes H; Shah P; Bains MS; Bott M; Isbell JM; Jones DR; Molena D
Ann Thorac Surg; 2018 Jul; 106(1):172-177. PubMed ID: 29627387
[TBL] [Abstract][Full Text] [Related]
3. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
4. Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro.
Cao W; Peters JH; Nieman D; Sharma M; Watson T; Yu J
Br J Cancer; 2015 Sep; 113(5):738-46. PubMed ID: 26263481
[TBL] [Abstract][Full Text] [Related]
5. Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved?
Betancourt Cuellar SL; Sabloff B; Carter BW; Benveniste MF; Correa AM; Maru DM; Ajani JA; Erasmus JJ; Hofstetter WL
Eur J Radiol; 2017 Mar; 88():56-60. PubMed ID: 28189209
[TBL] [Abstract][Full Text] [Related]
6. Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms.
Scarpa M; Kotsafti A; Fassan M; Scarpa M; Cavallin F; Nardi T; Pinto E; Alfieri R; Cagol M; Agostini M; Rugge M; Castagliuolo I; Castoro C
Tumour Biol; 2017 Oct; 39(10):1010428317728683. PubMed ID: 29022493
[TBL] [Abstract][Full Text] [Related]
7. Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study.
Cavallin F; Alfieri R; Scarpa M; Cagol M; Ruol A; Fassan M; Rugge M; Ancona E; Castoro C
BMC Surg; 2017 May; 17(1):49. PubMed ID: 28464907
[TBL] [Abstract][Full Text] [Related]
8. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
9. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
[TBL] [Abstract][Full Text] [Related]
10. Immune microenvironment in Barrett's esophagus adjacent to esophageal adenocarcinoma: possible influence of adjacent mucosa on cancer development and progression.
Gokon Y; Fujishima F; Taniyama Y; Ishida H; Yamagata T; Sawai T; Uzuki M; Ichikawa H; Itakura Y; Takahashi K; Yajima N; Hagiwara M; Nishida A; Ozawa Y; Sakuma T; Kanba R; Sakamoto K; Zuguchi M; Saito M; Kamei T; Sasano H
Virchows Arch; 2020 Dec; 477(6):825-834. PubMed ID: 32533341
[TBL] [Abstract][Full Text] [Related]
11. Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma.
Nobel TB; Barbetta A; Hsu M; Tan KS; Sihag S; Bains MS; Jones DR; Molena D
J Am Coll Surg; 2019 Oct; 229(4):366-373. PubMed ID: 31108196
[TBL] [Abstract][Full Text] [Related]
12. A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes.
Davison JM; Landau MS; Luketich JD; McGrath KM; Foxwell TJ; Landsittel DP; Gibson MK; Nason KS
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):369-377.e3. PubMed ID: 26515637
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification : impact of lymph node metastases on overall survival after esophagectomy.
Yamasaki M; Miyata H; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2014 Sep; 21(9):2850-6. PubMed ID: 24728822
[TBL] [Abstract][Full Text] [Related]
14. Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma.
Schiffmann LM; Göbel H; Löser H; Schorn F; Werthenbach JP; Fuchs HF; Plum PS; Bludau M; Zander T; Schröder W; Bruns CJ; Kashkar H; Quaas A; Gebauer F
BMC Cancer; 2019 May; 19(1):531. PubMed ID: 31151416
[TBL] [Abstract][Full Text] [Related]
15. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract][Full Text] [Related]
16. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
17. Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance.
Carraro A; Trevellin E; Fassan M; Kotsafti A; Lunardi F; Porzionato A; Dall'Olmo L; Cagol M; Alfieri R; Macchi V; Tedeschi U; Calabrese F; Rugge M; Castoro C; Vettor R; Scarpa M
Cancer Sci; 2017 Dec; 108(12):2393-2404. PubMed ID: 28985034
[TBL] [Abstract][Full Text] [Related]
18. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
20. Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.
Dijksterhuis WPM; Hulshoff JB; van Dullemen HM; Kats-Ugurlu G; Burgerhof JGM; Korteweg T; Mul VEM; Hospers GAP; Plukker JTM
Acta Oncol; 2019 Nov; 58(11):1640-1647. PubMed ID: 31397195
[No Abstract] [Full Text] [Related]
[Next] [New Search]